These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 29575905)

  • 21. Characterization of anti-CCR5 ribozyme-transduced CD34+ hematopoietic progenitor cells in vitro and in a SCID-hu mouse model in vivo.
    Bai J; Gorantla S; Banda N; Cagnon L; Rossi J; Akkina R
    Mol Ther; 2000 Mar; 1(3):244-54. PubMed ID: 10933940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can HIV be cured with stem cell therapy?
    Deeks SG; McCune JM
    Nat Biotechnol; 2010 Aug; 28(8):807-10. PubMed ID: 20697404
    [No Abstract]   [Full Text] [Related]  

  • 23. CCR5-edited gene therapies for HIV cure: Closing the door to viral entry.
    Haworth KG; Peterson CW; Kiem HP
    Cytotherapy; 2017 Nov; 19(11):1325-1338. PubMed ID: 28751153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Applications of Genome Editing to HIV Cure.
    Wang CX; Cannon PM
    AIDS Patient Care STDS; 2016 Dec; 30(12):539-544. PubMed ID: 27854119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lentivector Knockdown of CCR5 in Hematopoietic Stem and Progenitor Cells Confers Functional and Persistent HIV-1 Resistance in Humanized Mice.
    Myburgh R; Ivic S; Pepper MS; Gers-Huber G; Li D; Audigé A; Rochat MA; Jaquet V; Regenass S; Manz MG; Salmon P; Krause KH; Speck RF
    J Virol; 2015 Jul; 89(13):6761-72. PubMed ID: 25903342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combinatorial Strategies for Long-term Control of HIV Infection.
    Kwon D; Han MJ; Seo KW; Kang KS
    AIDS Rev; 2020 Dec; 22(4):175-182. PubMed ID: 33401284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene editing using a zinc-finger nuclease mimicking the CCR5Δ32 mutation induces resistance to CCR5-using HIV-1.
    Badia R; Riveira-Muñoz E; Clotet B; Esté JA; Ballana E
    J Antimicrob Chemother; 2014 Jul; 69(7):1755-9. PubMed ID: 24651827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hematopoietic-stem-cell-based gene therapy for HIV disease.
    Kiem HP; Jerome KR; Deeks SG; McCune JM
    Cell Stem Cell; 2012 Feb; 10(2):137-47. PubMed ID: 22305563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positive results with autologous transplant of ZFN-modified CD4 T-cells: a step toward a practical, functional cure for HIV.
    AIDS Patient Care STDS; 2011 Nov; 25(11):693. PubMed ID: 22023317
    [No Abstract]   [Full Text] [Related]  

  • 30. RNA-based anti-HIV-1 gene therapeutic constructs in SCID-hu mouse model.
    Bai J; Banda N; Lee NS; Rossi J; Akkina R
    Mol Ther; 2002 Dec; 6(6):770-82. PubMed ID: 12498773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene Editing: Regulatory and Translation to Clinic.
    Ando D; Meyer K
    Hematol Oncol Clin North Am; 2017 Oct; 31(5):797-808. PubMed ID: 28895848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination gene therapy for HIV using a conditional suicidal gene with CCR5 knockout.
    Mehmetoglu-Gurbuz T; Yeh R; Garg H; Joshi A
    Virol J; 2021 Jan; 18(1):31. PubMed ID: 33516234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical applications of genome editing in HIV.
    Wang CX; Cannon PM
    Blood; 2016 May; 127(21):2546-52. PubMed ID: 27053530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Strategies and Challenges of CCR5 Gene Editing in Hematopoietic Stem and Progenitor Cells for the Treatment of HIV.
    Karuppusamy KV; Babu P; Thangavel S
    Stem Cell Rev Rep; 2021 Oct; 17(5):1607-1618. PubMed ID: 33788143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CCR5 Δ32 homozygous cord blood allogeneic transplantation in a patient with HIV: a case report.
    Duarte RF; Salgado M; Sánchez-Ortega I; Arnan M; Canals C; Domingo-Domenech E; Fernández-de-Sevilla A; González-Barca E; Morón-López S; Nogues N; Patiño B; Puertas MC; Clotet B; Petz LD; Querol S; Martinez-Picado J
    Lancet HIV; 2015 Jun; 2(6):e236-42. PubMed ID: 26423196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted gene addition to human mesenchymal stromal cells as a cell-based plasma-soluble protein delivery platform.
    Benabdallah BF; Allard E; Yao S; Friedman G; Gregory PD; Eliopoulos N; Fradette J; Spees JL; Haddad E; Holmes MC; Beauséjour CM
    Cytotherapy; 2010 May; 12(3):394-9. PubMed ID: 20331411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors.
    Wang J; Exline CM; DeClercq JJ; Llewellyn GN; Hayward SB; Li PW; Shivak DA; Surosky RT; Gregory PD; Holmes MC; Cannon PM
    Nat Biotechnol; 2015 Dec; 33(12):1256-1263. PubMed ID: 26551060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autologous Hematopoietic Stem Cells transplantation and genetic modification of CCR5 m303/m303 mutant patient for HIV/AIDS.
    Esmaeilzadeh A; Farshbaf A; Erfanmanesh M
    Med Hypotheses; 2015 Mar; 84(3):216-8. PubMed ID: 25613565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Healing of HIV. Legitimate hope or utopia?].
    Oberhofer E
    MMW Fortschr Med; 2016 Jun; 158 Suppl 1():10. PubMed ID: 27259890
    [No Abstract]   [Full Text] [Related]  

  • 40. Bone marrow CD34(+) cells and megakaryoblasts secrete beta-chemokines that block infection of hematopoietic cells by M-tropic R5 HIV.
    Majka M; Rozmyslowicz T; Lee B; Murphy SL; Pietrzkowski Z; Gaulton GN; Silberstein L; Ratajczak MZ
    J Clin Invest; 1999 Dec; 104(12):1739-49. PubMed ID: 10606628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.